Literature DB >> 1537070

5-Fluorouracil's cytotoxicity is enhanced both in vitro and in vivo by concomitant treatment with hyperthermia and dipyridamole.

Y Maehara1, Y Sakaguchi, I Takahashi, M Yoshida, H Kusumoto, H Masuda, K Sugimachi.   

Abstract

We obtained evidence that the cytotoxic effect of 5-fluorouracil (5-FU) is augmented when the drug is given in combination with hyperthermia (HYP) and dipyridamole (DP). Nontoxic levels of DP enhanced the combined cytotoxicity of 5-FU and HYP against B16 melanoma and human tumor cells in vitro as measured by the succinate dehydrogenase inhibition (SDI) test. Growth of B16 melanoma that had been subcutaneously implanted into the feet of C57 BL mice was inhibited by treatment with the combinations of 5-FU and HYP, of 5-FU and DP, and of 5-FU, HYP and DP as compared with the administration of 5-FU alone. Treatment with HYP plus DP did not alter the body weight of mice that received 5-FU. The administration of DP plus HYP seemed to render the tumor cells more sensitive to 5-FU. The combination of 5-FU, HYP and DP shows promise for the treatment of patients suffering from malignant disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1537070     DOI: 10.1007/bf00685941

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  40 in total

1.  Studies on fluorinated pyrimidines. XI. In vitro studies on tumor resistance.

Authors:  C HEIDELBERGER; G KALDOR; K L MUKHERJEE; P B DANNEBERG
Journal:  Cancer Res       Date:  1960-07       Impact factor: 12.701

2.  Potentiation of 5-fluorouracil cytotoxicity by combining hyperthermia and dipyridamole in vitro.

Authors:  Y Maehara; Y Sakaguchi; T Kusumoto; H Kusumoto; K Sugimachi
Journal:  Anticancer Res       Date:  1989 Jul-Aug       Impact factor: 2.480

3.  Pharmacokinetics of intraperitoneally administered dipyridamole in cancer patients.

Authors:  T C Chan; G L Coppoc; S Zimm; S Cleary; S B Howell
Journal:  Cancer Res       Date:  1988-01-01       Impact factor: 12.701

4.  Comparison of the chemosensitivity of human neoplastic tissues between succinate dehydrogenase inhibition test and ATP assay.

Authors:  H Anai; Y Maehara; H Kusumoto; K Sugimachi
Journal:  Clin Chim Acta       Date:  1987-06-30       Impact factor: 3.786

5.  Potentiation of adriamycin cytotoxicity by dipyridamole against HeLa cells in vitro and sarcoma 180 cells in vivo.

Authors:  H Kusumoto; Y Maehara; H Anai; T Kusumoto; K Sugimachi
Journal:  Cancer Res       Date:  1988-03-01       Impact factor: 12.701

6.  The effect of whole body hyperthermia on 5-fluorouracil pharmacokinetics in vivo and clonogenicity of mammalian colon cancer cells.

Authors:  J Lange; K S Zänker; J R Siewert; G Blümel; K Eisler; E Kolb
Journal:  Anticancer Res       Date:  1984 Jan-Apr       Impact factor: 2.480

7.  Dipyridamole combination chemotherapy can be used safely in treating gastric cancer patients.

Authors:  Y Sakaguchi; Y Maehara; Y Emi; T Kusumoto; S Kohnoe; K Sugimachi
Journal:  Anticancer Drugs       Date:  1991-04       Impact factor: 2.248

8.  Colorectal carcinoma in vitro is more sensitive to 1-hexylcarbamoyl-5-fluorouracil compared with six other antitumor drugs: carboquone, Adriamycin, mitomycin C, aclacinomycin A, cisplatin, 5-fluorouracil.

Authors:  Y Maehara; H Anai; H Kusumoto; T Kusumoto; K Sugimachi
Journal:  Dis Colon Rectum       Date:  1988-01       Impact factor: 4.585

Review 9.  Enhancement of 5-fluorouracil's anticancer activity by dipyridamole.

Authors:  J L Grem; P H Fischer
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

10.  Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels.

Authors:  J L Grem; P H Fischer
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

View more
  2 in total

1.  Multi-chemothermoimmunotherapy for human colon adenocarcinoma in vitro.

Authors:  J Klostergaard; M E Leroux; H A Hsu; B P Hsi; Z H Siddik; L L Danhauser; S P Tomasovi
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

Review 2.  Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all.

Authors:  Arlene L Oei; Lianne E M Vriend; Johannes Crezee; Nicolaas A P Franken; Przemek M Krawczyk
Journal:  Radiat Oncol       Date:  2015-08-07       Impact factor: 3.481

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.